Human Albumin Solution — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

8 Recruiting

2 Completed trials

11 Sponsors

12 Countries

Phase III

Phase II

Phase IV

Phase III: 2 Phase II: 4 Phase I/II: 1 Phase IV: 3 Phase I (FiH): 1

Indications tested

Central nervous system neuroblastoma 1 Neuroblastoma 1 Myasthenia gravis 1 Intensive care 1 Endometrial cancer 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 1 Bonsai Biotherapeutics AB 1 Centre Hospitalier Universitaire De Nantes 1 Centre Oscar Lambret 1 CHRU De Nancy 1 Fakultni Nemocnice Hradec Kralove 1 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 1 Lipigon Pharmaceuticals AB 1 Prinses Maxima Centrum voor Kinderoncologie B.V. 1 Region Oestergoetland 1 Rigshospitalet 1

All trials

11 total

A double-blind, randomised, placebo-controlled, first-in-human (FIH) Phase I/IIa, multi-centre trial to assess safety, tolerability, and imm… Pending

2024-515627-10-00 Phase I (FiH) 3 countries Bonsai Biotherapeutics AB
The Intensive Care Platform Trial (INCEPT) Recruiting

2024-516208-41-00 Phase IV 5 countries Rigshospitalet
Effects of mesenchymal stem cells administration on organ failure during septic shock: Phase II randomized comprator-controlled study CHOC-M… Recruiting

2024-518019-20-00 Phase II 1 country CHRU De Nancy
Modulation of the Extent of Ischemic Brain Damage by Protecting the Endothelial Glycocalyx with Low-Dose Albumin Administration (MOZEG) Recruiting

2023-509261-20-00 Phase II 1 country Fakultni Nemocnice Hradec Kralove
ALBU-CHIP - Efficacy of human 20% albumin solution + Ringer Lactate versus Ringer Lactate for fluid replacement strategy during cytoreductiv… Recruiting

2024-510943-76-00 Phase III 1 country Assistance Publique Hopitaux De Paris
HALT : Influence of Human Albumin supplementation on kidney dysfunction after Liver Transplantation Recruiting

2024-514804-14-00 Phase IV 1 country Centre Hospitalier Universitaire De Rennes
Phase Ib study combining dinutuximab beta with induction chemotherapy regimens in patients with newly diagnosed high-risk neuroblastoma Recruiting

2023-509673-22-00 Phase I/II 7 countries Prinses Maxima Centrum voor Kinderoncologie B.V.
Validation of ICG-99mTc-nanoscan as hybrid tracer for sentinel node biopsy Recruiting

2024-519351-28-00 Phase II 1 country Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Comparison of albumin and Ringer´s solution for optimization of the plasma volume and hemodynamics during surgery Recruiting

2024-513159-33-00 Phase IV 1 country Region Oestergoetland
RANDOMIZED STUDY COMPARING SENTINEL NODE POLICY TO CURRENT INITIAL STAGING PROTOCOLS IN EARLY STAGE ENDOMETRIAL CARCINOMAS AT INTERMEDIATE A… Ended

2024-513079-42-00 Phase III 1 country Centre Oscar Lambret
A24110He in a placebo-controlled trial evaluating safety in subjects with elevated plasma triglycerides Ended

2023-509091-42-00 Phase II 1 country Lipigon Pharmaceuticals AB

Showing 1–11 of 11 trials

← All drugs A–Z